An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.
| Excerpt | Reference |
|---|
| "Sarcoidosis is a disease of unknown etiology that is characterized by the generalized formation of granulomas and is accompanied by elevation in the serum in less than half the patients of angiotensin converting enzyme, a dipeptidyl carboxypeptidase that catalyzes the conversion of the decapeptide, angiotensin I, to the pressor octapeptide, angiotensin II, and L-histidyl-L-leucine." | ( Friedland, J; Gourin, A; Lyons, HA; Silverstein, E, 1976) |
| "Skeletal sarcoidosis is rare in early stages (Löfgren-syndrom), relatively frequent in late stages." | ( Uehlinger, E; Wurm, K, 1976) |
| "Three cases of neurosarcoidosis are reported, which demonstrate almost the complete spectrum of known neurological symptoms in this disease." | ( Harrer, G; Pilz, P, 1979) |
| "Pulmonary sarcoidosis is found more often in females than males (60:40)." | ( Kostina, SI, 1977) |
| "Sarcoidosis is a disease of unknown etiology with protean manifestations." | ( Callen, JP; Chanda, JJ, 1978) |
| "A primary orbital sarcoidosis is described with probable optic nerve involvement and later intraocular invasion in the form of a single candle spot-shaped chorioretinitis." | ( Strempel, I, 1977) |
| "Although ocular sarcoidosis is usually manifested by anterior segment inflammation, it is apparent that it may also produce proliferative lesions of the optic nerve." | ( Burns, CL, 1976) |
| "Sarcoidosis is seldom associated with Waldenström's macroglobulinaemia." | ( Boulitrop-Morvan, C; Camus, P; Collet, E; Dalac, S; Lambert, D, 1992) |
| "Sarcoidosis is a systemic disease, and uveitis is considered the hallmark of ophthalmic sarcoidosis." | ( Ichijo, K; Mochizuki, T; Nakamura, M; Takehara, Y, 1992) |
| "Neurosarcoidosis is a well-recognised complication of systemic sarcoidosis but diagnosis may be difficult if there is no clear evidence of an extracerebral manifestation of the disease." | ( Dichgans, J; Petersen, D; Sommer, N; Weller, M; Wiethölter, H, 1991) |
| "Sarcoidosis is a granulomatous disorder of unknown aetiology." | ( Garred, P; Hetland, G; Johnson, E; Mollnes, TE; Osen, SS; Pettersen, HB, 1990) |
| "Sarcoidosis is a systemic granulomatous disease of undetermined cause, with cutaneous manifestations occurring in up to 35 percent of patients." | ( Bruce, S; Matarasso, SL, 1991) |
| "Sarcoidosis is a multisystem disorder of unknown etiology that frequently involves the lymph nodes, lungs, eyes, and skin." | ( Bell, NH, 1991) |
| "Neurosarcoidosis is an underdiagnosed variant of the systemic disease." | ( Kristt, DA; Panitch, HS; Sauter, MK, 1991) |
| "Sarcoidosis is a multisystem granulomatous disorder that rarely involves the spinal cord." | ( Cross, LL; Meythaler, JM; Tuel, SM, 1991) |
| "Cardiac sarcoidosis is increasingly diagnosed in the last few decades." | ( Alberts, C; David, GK; de Blok, K; Düren, DR, 1991) |
| "Sarcoidosis is a generalized disorder which involves the central nervous system in 5 per cent of patients presenting with the disease." | ( Ferlinz, R; Fischer, B; Müller-Quernheim, J, 1991) |
| "The alveolitis of sarcoidosis is dominated by lymphocytes and mononuclear phagocytes and chronic macrophage activation may play a role in the pulmonary interstitial fibrosis of sarcoidosis." | ( Frederiksen, J; Milman, N; Nielsen, H; Sherson, D, 1990) |
| "Symptomatic sarcoidosis is usually treated with glucocorticoids; however, glucocorticoids are associated with significant morbidity." | ( Baughman, RP; Lower, EE, 1990) |
| "Sarcoidosis is a well-established cause of ocular neovascularization." | ( Brown, GC; Duker, JS; McNamara, JA, 1988) |
| "Sarcoidosis is a disease in which the proliferation of monocyte-macrophage-derived cells is observed." | ( Almenoff, JS; Fagerstrom, R; Gilbert, HS; Ginsberg, H; Kindman, LA; Teirstein, AS, 1989) |
| "Sarcoidosis is a multisystem disease, but the lungs are almost always involved." | ( Selroos, OB, 1986) |
| "Sarcoidosis is a multisystem granulomatous disease of unknown cause." | ( Anderson, RL; Jordan, DR; Nerad, JA; Patrinely, JR; Scrafford, DB, 1988) |
| "Sarcoidosis is a multisystem disease with a 90% prevalence of lung involvement." | ( Dolovich, M; Jordana, M; Newhouse, M, 1987) |
| "Sarcoidosis is being increasingly recognized in India." | ( Bambery, P; Behera, D; Deodhar, SD; Gupta, AK; Jindal, SK; Kaur, U; Malik, SK, 1987) |
| "Renal impairment in sarcoidosis is unusual: cases with granulomatous interstitial nephritis (GIN) and without associated glomerular disease, nephrocalcinosis and hypercalcemia have rarely been described." | ( Evans, DJ; Singer, DR, 1986) |
| "Sarcoidosis is frequently attended by hypercalciuria and sometimes by hypercalcaemia." | ( Battesti, JP; Bouillon, R; Georges, R; Meyrier, A; Paillard, F; Valeyre, D, 1985) |
| "Five cases of neurosarcoidosis are described in which serious neurological involvement was the presenting manifestation of the disease." | ( Elkin, R; Willcox, PA, 1985) |
| "Pulmonary sarcoidosis is a disease characterized by an increased number and activity of lymphocytes in the lung." | ( Baughman, RP; Dohn, M; Strohofer, S, 1985) |
| "Sarcoidosis is a multisystem disease of unknown etiology characterized by non-caseating granulomatous inflammation of various organs, but most frequently involving the lungs of young adults." | ( deSa, D; Leahy, F; Mina, M, 1985) |
| "Serum ACE levels in sarcoidosis are all higher when the disease is diffuse from a pulmonary and extrapulmonary standpoint." | ( Basset, G; Battesti, JP; Lecossier, D; Sandron, D, 1982) |
| "Sarcoidosis is characterised by changes in the lymphocyte subpopulations of the peripheral venous blood in the majority of patients." | ( Davies, BH; Jones, K; Jones-Williams, W; Smith, MD; Williams, JD, 1982) |
| "The active stage of sarcoidosis is marked by lymphocyte-rich alveolitis with predominance of helper-T-lymphocytes." | ( Bauer, W; Baumann, HR; Morell, A; Simona, R, 1984) |
| "Especially when sarcoidosis is suspected to be the cause of hypercalcaemia, SACE measurement may be useful as a rapid diagnostic guide." | ( Rømer, FK, 1982) |
| "Familial sarcoidosis is rare." | ( Flanagan, J; Nowinski, T; Ruchman, M, 1983) |
| "Sarcoidosis is suggested to be a granulomatous disease with high-turnover characteristics." | ( Broekhuizen-Davies, JM; Stam, J; van der Gaag, RD; van Maarsseveen, AC, 1983) |
| "Pleural sarcoidosis is rare--it is little recognised in Birtian although several cases have been reported in the international literature." | ( Friend, JA; Legge, JS; Nicholls, AJ, 1980) |
| "The outcome of sarcoidosis is generally favorable, however, some patients progress to pulmonary fibrosis." | ( Klech, H; Köhn, H; Kummer, F; Micksche, M; Pohl, WR; Rennard, SI; Umek, H, 1993) |
| "Scar sarcoidosis is one of the rare cutaneous manifestations of sarcoidosis." | ( Abd-el-Raheem, T; Landthaler, M; Pfau, A, 1995) |
| "Sarcoidosis is a multisystemic granulomatosis of unknown etiology which mainly affects young adults." | ( Baculard, A; Gallas, D; Garabedian, EN; Roger, G; Tashjian, G; Tournier, G, 1994) |
| "Sarcoidosis is a chronic multisystem granulomatous disease that has a predilection for pulmonary and upper respiratory tract involvement." | ( Aner, M; Krespi, YP; Kuriloff, DB, 1995) |
| "Sarcoidosis is a systemic granulomatous process of unknown cause." | ( DeRemee, RA, 1995) |
| "Sarcoidosis is a multisystemic disease of unknown etiology with characteristic picture of immunological disorders." | ( Podwysocki, B, 1994) |
| "Childhood sarcoidosis is a rare disorder with protean manifestations." | ( Ilowite, N; Kwong, T; Paley, C; Valderrama, E, 1994) |
| "Nasosinusal Sarcoidosis is an uncommon entity setting forth diagnostical and therapeutical questions to be answered." | ( Armengot, M; Basterra, J; Febrer, I; Ferrando, J, 1994) |
| "Sarcoidosis is a systemic granulomatous disorder of unknown origin." | ( Bartlett, R; Haller, S; Müller-Quernheim, J; Pfeifer, S; Strausz, J, 1994) |
| "Since sarcoidosis is a disorder of cell proliferation and differentiation, a question has been always kept in my mind whether the sarcoid granulomas are chronic inflammation per se or neoplastic in nature." | ( Okabe, T, 1994) |
| "Sarcoidosis is a systemic inflammatory disease of unknown etiology characterized by non-caseating epithelioid cell granulomata." | ( Hung, W; Lipnick, RN; Pandian, MR, 1993) |
| "A case of sarcoidosis is described which presented with hypercalcaemia and renal insufficiency." | ( Boon, ES; Brombacher, PJ; Cozijn, D, 1993) |
| "Neurosarcoidosis is exceedingly rare in the pediatric age groups." | ( Bader-Meunier, B; Dommergues, JP; Jullien, M; Parker, F; Rey, C, 1993) |
| "Sarcoidosis is exceptionally revealed by major isolated hypercalcemia." | ( Mathis, C; Maugars, Y; Prost, A; Vilon, P, 1993) |
| "Sarcoidosis is a systemic granulomatous disease, which can affect the vestibulo-acoustic system at any level, causing vertigo and/or hearing loss." | ( Brihaye, P; Halama, AR, 1993) |
| "Sarcoidosis is a granulomatous disease of unknown etiology that may involve any organ or tissue of the body." | ( Inoh, M; Kurata, N; Oti, T; Ozaki, M; Tarumi, Y, 1995) |
| "Cardiac sarcoidosis is characterized by a high incidence of complete atrioventricular block, right bundle branch block, and ventricular arrhythmias." | ( Iijima, T; Iwashita, H; Kumazawa, T; Matsukawa, T; Ookawa, I; Sato, I, 1995) |
| "Sarcoidosis is a granulomatous disease of unknown aetiology, which may affect various organs." | ( Hoffmann, AL; Milman, N, 1996) |
| "Sarcoidosis is sometimes associated with hypercalcemia, but rarely with renal dysfunction." | ( Hayakawa, N; Hironaka, K; Kageyama, J; Kashihara, N; Kawabata, K; Maeshima, Y; Makino, H; Mimura, Y; Nagake, Y; Ogura, T; Ota, Z, 1996) |
| "Sarcoidosis is rarely recognized as an osseous manifestations alone." | ( Benelhadj, S; Bérolatti, B; Duet, M; Mundler, O; Patrois, F, 1996) |
| "Cardiac sarcoidosis is a disease of young adults." | ( Gill, JS; Gupta, J; Lip, GY; Singh, SP, 1996) |
| "Sarcoidosis is a multi-system, non-caseating granulomatous disease of unknown etiology." | ( Ku, A; Lachmann, E; Nagler, W; Tunkel, R, 1996) |
| "Sarcoidosis is a common granulomatous systemic inflammatory disease mainly affecting the interstitial lung tissue and perihilar lymph nodes." | ( Heymer, B; Pirsig, W; Verse, T, 1997) |
| "Sarcoidosis is a multisystem disorder of unknown causes, characterized by widespread noncaseating epithelioid cell granuloma in more than one organ." | ( Chen, JH; Hsieh, WC; Perng, RP; Tsai, TT, 1997) |
| "Sarcoidosis is a systemic disease defined by multiple granulomas." | ( Bodokh, I; Brun, P; Majcwrczyk, N; Mayaffre, C; Montagne, M, 1998) |
| "Although sarcoidosis is predominantly a pulmonary disorder, it often produces disease in the head and neck." | ( Baum, ED; Boudousquie, AC; Li, S; Mirza, N, 1998) |
| "Sarcoidosis is a relatively common, chronic, multisystem disease of unknown origin." | ( Das, D; Smith, A; Warnes, TW, 1999) |
| "Extracutaneous sarcoidosis is rarely associated." | ( Croué, A; François, S; Maillard, H; Verret, JL, 1998) |
| "Sarcoidosis is an enigmatic disease with extremely variable manifestations in pattern, severity and course." | ( Johns, CJ; Michele, TM, 1999) |
| "Neurosarcoidosis is exceptional in this age group and seldom suspected when the neurologic symptoms are present." | ( Girard, N; Koné-Paut, I; Portas, M; Raybaud, C; Wechsler, B, 1999) |
| "Sarcoidosis is a multisystem disorder in which the lungs or intrathoracic lymph nodes are involved in more than 90% of patients with the disease." | ( Doğukan, A; Oymak, O; Oymak, S; Patiroğlu, TE; Utaş, C, 1999) |
| "Sarcoidosis is a multiple-system disorder of unknown origin characterized histologically by epithelioid granulomas with little or no necrosis." | ( Gogstetter, DS; Goldsmith, LA, 1999) |
| "Sarcoidosis is a chronic multisystemic granulomatous disease of unknown etiology." | ( Craver, RD; Dimitriades, C; Gedalia, A; Shetty, AK; Vehaskari, M, 1999) |
| "Sarcoidosis is a rare cause of renal failure and it has been associated with a wide spectrum of renal manifestations, including granulomatous interstitial nephritis." | ( Antón Badiola, I; Gómez Rodríguez, N; Vasconez Espinosa, F, 1999) |
| "The diagnosis of sarcoidosis is sometimes difficult when its clinical manifestations are uncommon." | ( Fukami, T; Kumamoto, T; Miyazaki, E; Mori, T; Sawabe, T; Sugisaki, K; Tsuda, T, 2000) |
| "Sarcoidosis is a multisystemic disorder that may involve every organ." | ( Erbel, R; Kuntz, S; Oldenburg, O; Philipp, T; Sack, S; Schäfers, RF; Weber, F, 2000) |
| "Sarcoidosis is a systemic chronic granulomatous disease of unknown etiology most commonly affecting young females." | ( Blichert-Toft, M; Christensen, L; Feldt-Rasmussen, U; Hansen, HS; Kirkegaard, J; Zimmermann-Belsing, T, 2000) |
| "Sarcoidosis is a disease that exhibits extremely heterogeneous clinical manifestations." | ( Bharadwaj, P; Sharma, OP; Wilcox, A, 2000) |
| "Sarcoidosis is a systemic granulomatous disease of unknown origin, characterized in affected organs by an accumulation of activated T lymphocytes and macrophages." | ( Pettersson, T, 2000) |
| "Spinal neurosarcoidosis is rare (0." | ( Cacoub, P; Capelle, L; Dormont, D; Fohanno, D; Hausfater, P; Piette, JC; Sbaï, A, 2000) |
| "Sarcoidosis is a multisystem disease of unknown etiology." | ( Gibson, LE; Kim, YC; Triffet, MK, 2000) |
| "Sarcoidosis is a relatively common, chronic, multisystem disease of unknown origin characterized by the presence of noncaseating epithelioid granulomas." | ( Boehme, MW; Hofmann, WJ; Mueller, S; Stremmel, W, 2000) |
| "Sarcoidosis is a chronic systemic granulomatous disease that occasionally affects the larynx." | ( Fradis, M; Golz, A; Löhle, E; Ridder, GJ; Strohhäcker, H, 2000) |
| "Sarcoidosis is thought to be a type-1 cytokine-mediated disorder." | ( Chida, K; Inui, N; Nakamura, H; Suda, T, 2001) |
| "Sarcoidosis is a multisystem granulomatous disease of unknown origin." | ( Bergoin, C; Lamblin, C; Wallaert, B, 2001) |
| "Sarcoidosis is a multisystem granulomatous disease of unknown etiology that can affect almost every organ in the body, particularly the lungs, skin, eyes, and thoracic lymph nodes." | ( Dios, E; Herreras, JM; Saornil, MA, 2001) |
| "Acute cutaneous sarcoidosis is generally spontaneously regressive but persistent chronic cutaneous lesions are esthetically prejudicial." | ( Bressieux, JM; Cosnes, A; Estines, O; Revuz, J; Roujeau, JC; Wolkenstein, P, 2001) |
| "Sarcoidosis is a chronic disorder of unknown etiology characterized by the development of non-caseating granulomas with derangement of the normal tissue architecture." | ( Kupsky, WJ; Rengachary, S; Viñas, FC, 2001) |
| "Sarcoidosis is a multisystemic disease of unknown origin characterized pathologically by the presence of noncaseating epithelioid granulomas." | ( Cérez, D; Frédy, D; Méary, E; Meder, J; Zylberberg, F, 2001) |
| "Sarcoidosis is a multisystemic granulomatosis disease of unknown etiology which commonly involves hilary nodes and lungs." | ( Cacoub, P; Capelle, L; Fohanno, D; Pierre-Kahn, V; Piette, JC; Sbaï, A, 2001) |
| "Sarcoidosis is a chronic systemic disease, characterized by an imbalance of immunity processes and the presence of granuloma." | ( Caliumi, C; Cerci, S; D'Erasmo, E; Danese, A; Delfini, E; Letizia, C; Reale, MG; Subioli, S, 2001) |
| "Sarcoidosis is one in a heterogeneous family of granulomatous disorders." | ( Oliver, SJ, 2002) |
| "Interferon-induced sarcoidosis is well documented." | ( Beylot, C; Beylot-Barry, M; Cogrel, O; Couzigou, P; Doutre, MS; Marlière, V, 2002) |
| "Sarcoidosis is systemic granulomatous disorder." | ( Agarwal, V; Aggarwal, A; Govindarajan, V; Misra, R, 2001) |
| "Arthritis in sarcoidosis is an early manifestation of disease and may mimic reactive or rheumatoid arthritis." | ( Agarwal, V; Aggarwal, A; Govindarajan, V; Misra, R, 2001) |
| "Sarcoidosis is a chronic granulomatous disorder characterized by multisystem involvement, however, symptomatic thrombocytopenia as a presenting manifestation is rare." | ( Agarwal, A; Agarwal, V; Gupta, RK; Mishra, R; Pal, S, 2002) |
| "Sarcoidosis is a disorder characterized by macrophage- and T-cell-mediated responses to as yet unidentified infectious antigens or autoantigens." | ( Katoh, N; Mihara, H; Yasuno, H, 2002) |
| "Neurosarcoidosis is a rare, but well-recognized cause of hypopituitarism with a predilection for the hypothalamus." | ( Bouloux, PM; Chamoun, V; Davison, R; Randeva, HS, 2002) |
| "Sarcoidosis is a systemic granulomatous disease that affects various organs." | ( Fukuchi, Y; Miura, K; Takahashi, K, 2002) |
| "Sarcoidosis is a chronic systemic disease of unknown causes characterized by noncauseating granuloma in various organs." | ( Iizuka, T; Sakai, F, 2002) |
| "Sarcoidosis is a systemic granulomatous disease that the epidemiology remains unknown." | ( Konishi, M; Takahashi, K; Yoneda, K; Yoshimoto, E, 2002) |
| "Cutaneous sarcoidosis is rare in children." | ( Hardman, C; Hunt, SJ; O'toole, E; Philips, W; Wakelin, SH; Walters, S, 2002) |
| "Sarcoidosis is a multisystem disease of unknown origin characterized by the formation of noncaseating granulomas, in particular in the lungs, lymph nodes, eyes, and skin." | ( Altmeyer, P; Gambichler, T; Hanefeld, C; Kastner, U; Nowack, U, 2002) |
| "Sarcoidosis is an inflammatory disease with potentially severe mucocutaneous manifestations." | ( Kouba, DJ; Mimouni, D; Nousari, HC; Rencic, A, 2003) |
| "Patients with sarcoidosis are at risk for osteoporosis caused by glucocorticoid therapy." | ( Adler, RA; Berger, MM; Funkhouser, HL; Petkov, VI, 2003) |
| "Sarcoidosis is an independent risk factor for cryptococcal infection; most patients with sarcoidosis who develop cryptococcal infection are not on immunosuppressive drugs." | ( Katz, JD; Ross, JJ, 2002) |
| "Sarcoidosis is a disease process of unknown cause that exhibits heterogeneous clinical manifestations." | ( Delbeke, D; Fordice, S; Lamar, R; Ludwig, V; Martin, WH, 2003) |
| "Neurosarcoidosis is a great mimicker." | ( Lewis, RA; Shah, JR, 2003) |
| "Sarcoidosis is a multisystemic disease which involves the nervous system in 5 to 15 p." | ( Boncoeur, MP; Couratier, P; Delage-Corre, M; Denes, E; Kort, L; Moufid, A, 2003) |
| "Neurosarcoidosis is a rare disorder in which psychosis and dementia may occur." | ( Friedman, SH; Gould, DJ, 2002) |
| "Sarcoidosis is now recognised as a member of a large family of granulomatous disorders and has been reported from all parts of the world." | ( Mohan, A; Sharma, SK, 2002) |
| "Sarcoidosis is a systemic disorder of unknown etiology characterized by its pathological hallmark, the noncaseating granuloma." | ( Khanna, D; Liebling, MR; Louie, JS, 2003) |
| "Sarcoidosis is a chronic generalized benign granulomatous disorder of perhaps an autoimmune character which can afflict many organs." | ( Bol, P, 2003) |
| "Sarcoidosis is a multisystem granulomatous disease of unknown etiology." | ( Calis, HT; Karayel, T; Ozaras, N; Ozaras, R; Sipahi, S; Tuzun, F; Tuzun, S, 2004) |
| "Sarcoidosis is a multi-system, non-caseating granulomatous disease of unknown aetiology that may affect any organ." | ( Aguirre, A; Fischman, SL; Martinez Calixto, LE; Suresh, L, 2004) |
| "Sarcoidosis is a granulomatous, multisystem disease." | ( Gujral, JS; Ponce, C, 2004) |
| "Cardiac sarcoidosis is potentially fatal and hence requires a precise diagnosis." | ( Dohi, Y; Ikeda, K; Ito, Y; Iwase, M; Nakazawa, A; Sato, K; Ueda, R, 2004) |
| "Pancreatic sarcoidosis is a rare entity, and few reports in the literature describe the CT aspects of the disease." | ( Baroni, RH; Goldsmith, J; Pedrosa, I; Rofsky, NM; Tavernaraki, E, 2004) |
| "Sarcoidosis is immunologically characterized by highly enhanced Th1 responses in active stage." | ( Abe, S; Hiraga, Y; Sato, N; Shigehara, K; Shijubo, N; Takahashi, R, 2004) |
| "Sarcoidosis is a systemic granulomatous disease of unknown etiology and is associated with a wide variety of renal disorders including nephrolithiasis, hypercalciuria, hypercalcemia, nephrocalcinosis, tubular defect, glomerulonephritis, and granulomatous interstitial nephritis." | ( Arase, S; Hanaoka, K; Hano, H; Horino, T; Hosoya, T; Kawaguchi, Y; Kawamura, T; Mitome, J; Okada, H; Osaka, N; Shimada, T; Yamaguchi, Y, 2004) |
| "Sarcoidosis is a chronic granulomatous multisystem disease in which arthritis is relatively common." | ( Cushley, MJ; Erb, N; Kassimos, DG; Kitas, GD; Shave, RM, 2005) |
| "Many patients with sarcoidosis are unable to tolerate corticosteroids or alternative therapeutic agents due to side effects or have disease refractory to these agents." | ( Doty, JD; Judson, MA; Mazur, JE, 2005) |
| "Neurosarcoidosis is a rare manifestation of sarcoidosis." | ( Hayat, GR; Kaiboriboon, K; Olsen, TJ, 2005) |
| "Sarcoidosis is a multisystem granulomatous disease of unknown aetiology, most commonly affecting young adults." | ( Clément, A; Fauroux, B, 2005) |
| "Sarcoidosis is a chronic, systemic inflammatory disease of unknown etiology, characterized by noncaseating granulomatous infiltration of any organ." | ( Güvenç, B; Güvenç, H; Hanta, I; Unsal, A; Unsal, C, 2005) |
| "The diagnosis of sarcoidosis is most secure when supported by a tissue biopsy exhibiting noncaseating epithelioid granulomas with absence of known granulomagenic agents in a patient with multi-organ disease." | ( Baughman, RP; Judson, MA; Moller, DR; Rossman, MD; Teirstein, AS; Yeager, H, 2005) |
| "Biopsy diagnosis in sarcoidosis is almost always easily obtained." | ( Baughman, RP; Judson, MA; Moller, DR; Rossman, MD; Teirstein, AS; Yeager, H, 2005) |
| "Cardiac sarcoidosis is a disease of young adults." | ( Daud, MS; Swaminathan, M; Wan Muhaizan, WM, 2004) |
| "Systemic sarcoidosis is often diagnosed late." | ( Duet, M; Fayad, F; Lioté, F; Orcel, P, 2006) |
| "Sarcoidosis is a multi-system granulomatous disorder of unknown etiology with symptomatic cardiac involvement in up to 7% of patients." | ( de Klerk, PA; Doubell, AF; Smedema, JP; Truter, R; White, L; Zaaiman, L, 2006) |
| "Sarcoidosis is a systemic granulomatous disease primarily involving the lungs, lymph nodes, skin, eyes and nervous system; liver involvement is asymptomatic in most cases." | ( Cengiz, C; deBoccardo, G; Emre, S; Fiel, MI; Kovacevic, M; Rodriguez-Davalos, M; Rodriguez-Laiz, G; Schiano, T, 2005) |
| "Sarcoidosis is a multi-system disorder characterized by non-caseating epithelioid granulomas in multiple organs." | ( Kher, KK; Moudgil, A; Przygodzki, RM, 2006) |
| "Sarcoidosis is a multisystem disease with various clinical manifestations." | ( Agrawal, Y; Belafsky, PC; Godin, DA, 2006) |
| "Sarcoidosis is a chronic relapsing multi-systemic disorder characterized by the development of non-caseating granulomas." | ( Raftery, MJ; Rajakariar, R; Sharples, EJ; Sheaff, M; Yaqoob, MM, 2006) |
| "Sarcoidosis is a non-caseating granulomatous systemic disease of unknown pathogenesis, and cardiac involvement is the most important prognostic factor." | ( Hosokawa, R; Kanao, S; Kimura, T; Kita, T; Tadamura, E; Togashi, K; Wu, YW; Yamamuro, M, 2007) |
| "Sarcoidosis is a systemic, chronic inflammatory disease characterized by non-caseating epithelioid granuloma." | ( Ito, T; Iwasaki, Y; Kobayashi, H; Kubota, K; Kuroda, S; Maruichi, K; Yamaguchi, S, 2006) |
| "Sarcoidosis is generally treated with corticosteroids that are not always an effective therapy." | ( Rott, T; Rylander, R; Tercelj, M, 2007) |
| "Sarcoidosis is a multisystemic disease that usually involves the lungs and lymph nodes, but almost any organ can be involved." | ( Amzuta, IG; Lai, RS; Lenox, RJ; Nasr, MR; Vasu, TS, 2006) |
| "Sarcoidosis is a granulomatous disease of unknown etiology and is only rarely seen in infants and children." | ( Bartram, U; Bauer, J; Schranz, D; Thul, J; Wössmann, W, 2006) |
| "Sarcoidosis is a multisystem, inflammatory disorder characterized by infiltration of any organ with non-caseating granuloma." | ( Butun, B; Cay, F; Kacar, C; Sezer, I; Tuncer, T, 2007) |
| "Patients with sarcoidosis are at risk of opportunistic infections both from the sarcoidosis itself and from steroid therapy." | ( Chianura, L; Cirasino, L, 2006) |
| "Sarcoidosis is a multisystem granulomatous disease that may affect any organ." | ( Ide, K; Koike, K; Komune, S; Nakashima, T; Shiratsuchi, H; Umezaki, T, 2007) |
| "Sarcoidosis is uncommon in children." | ( Boue, DR; Henwood, MJ; Lo, WD; Rusin, JA; Tsao, CY, 2007) |
| "Spinal sarcoidosis is rare." | ( Bonuccelli, U; Caneparo, D; Cipriani, G; Fazzi, P; Lucetti, C; Nuti, A; Tessa, C, 2007) |
| "Interferon-induced sarcoidosis is well documented." | ( Honsová, E; Sperl, J; Sticová, E, 2007) |
| "Sarcoidosis is a multisystem granulomatous disease of unknown aetiology with variable manifestations, which may affect virtually any organ." | ( Fujita, Y; Nemoto, I; Shimizu, H; Shimizu, T; Tateishi, Y; Tsuji-Abe, Y, 2007) |
| "Neurosarcoidosis is a rare (5 cases for one million) immune-mediated disease generally observed in young adults." | ( Bourg, V; Chanalet, S; Chaussenot, A; Fornari, JM; Lebrun, C, 2007) |
| "Sarcoidosis is a systemic inflammatory disease clinically characterized by swelling of bilateral hilar lymph nodes and histologically defined by non-caseating epithelioid cell granulomas." | ( Kanazawa, N, 2007) |
| "Early onset sarcoidosis is a granulomatous disease which is characterized by synovitis, polyarthritis, skin and eye involvement." | ( Autschbach, F; Blank, N; Libicher, M; Lorenz, HM; Max, R, 2007) |
| "Sarcoidosis is a multisystemic granulomatous disease of unknown aetiology mainly affecting African-Americans, Scandinavians, and the Irish." | ( Liza-Sharmini, AT; Ramlee, N; Ramli, N, 2007) |
| "Generally, sarcoidosis is identified clinically in patients with foggy vision or mediastinal lymphadenopathy, but muscular weakness may be an infrequently observed initial symptom." | ( Goto, D; Ishii, W; Ito, S; Iwanami, K; Mamura, M; Matsumoto, I; Ogishima, H; Sumida, T; Suzuki, T; Tsutsumi, A; Yamada, H, 2007) |
| "Sarcoidosis is increasingly diagnosed in developing countries, although it was earlier thought to be uncommon." | ( Bajwa, G; Khanna, A; Malhotra, V; Sidhu, U, 2007) |
| "Hypercalcemia in sarcoidosis is due to the uncontrolled synthesis of 1,25-dihydroxyvitamin D3 by macrophages." | ( Ackermann, D, 2007) |
| "Sarcoidosis is a multi-system granulomatous disease of unknown etiology with worldwide distribution." | ( Hammond, ER; Kaplin, AI; Kerr, DA, 2007) |
| "Sarcoidosis is a systemic disease of unknown cause with various clinical and radiologic manifestations." | ( Clarençon, F; Fernandez, P; Feydy, A; Hourseau, M; Kerrou, K; Lebreton, C; Marchand-Adam, S; Schouman-Claeys, E; Silbermann-Hoffman, O, 2007) |
| "Although ocular sarcoidosis is often accompanied by secondary glaucoma or optic nerve atrophy, the progression of neurosarcoidosis can lead to visual field defects." | ( Asukata, Y; Hasumi, Y; Hayashi, K; Ishihara, M; Mizuki, N; Nakamura, S; Nishida, T, 2007) |
| "Sarcoidosis is an ubiquity disease, which can infiltrate all tissues." | ( Ben Gamra, O; Bousaffa, H; Chedly, I; El Khedim, A; Hariga, I; Khayat, O; Ktari, S; M'Barek, C; Zribi, S, 2007) |
| "Sarcoidosis is a systemic granulomatous disease that is triggered by an autoimmune process, and is now a well recognized but uncommon complication of antiviral therapy for Hepatitis C virus (HCV) infection, likely related to its immunomodulatory effects." | ( Dinihan, I; Freiman, J; Yan, KK; Zekry, A, 2008) |
| "Sarcoidosis is an inflammatory granulomatous systemic disease that rarely affects the oral cavity." | ( Antunes, KB; Azevedo, AL; Carvalho, SR; Miranda, AM; Pires, FR; Tatakis, DN, 2008) |
| "Although sarcoidosis is a systemic disease that rarely affects the gingiva, the possibility of gingival involvement as the sole manifestation of the disease should be considered in the differential diagnosis of gingival lesions." | ( Antunes, KB; Azevedo, AL; Carvalho, SR; Miranda, AM; Pires, FR; Tatakis, DN, 2008) |
| "Sarcoidosis is a multisystemic disease which diagnosis depends on the presence of nonnecrotizing granulomas in the biopsy." | ( Callejas-Rubio, JL; Guerrero Fernández, M; Ortego-Centeno, N; Ríos Fernández, R; Serrano Falcón, MM, 2008) |
| "Sarcoidosis is a systemic disease that histologically typically shows non-caseating granulomas." | ( Mulligan, ME; Smith, S; Talmi, D, 2008) |
| "Sarcoidosis is a multisystem disease of unknown etiology." | ( Halbritter, J; Mayer, C; Müller, A; Stumvoll, M; Wirtz, H, 2008) |
| "Sarcoidosis is a chronic inflammatory disease of unknown cause, characterized by granuloma formation similar to tuberculosis, but without clear evidence of a microbial infection." | ( Bauer, KL; Bhardwaj, N; Fischoeder, A; Mathew, S; Oliver, SJ, 2008) |
| "Sarcoidosis is a multisystemic granulomatous disease with an unpredictable clinical course characterized by accumulation of activated proliferating T lymphocytes and mononuclear phagocytes in affected organs." | ( Bargagli, E; Bianchi, N; Coviello, G; Grosso, S; Luddi, A; Margollicci, M; Olivieri, C; Rottoli, P, 2008) |
| "Neurosarcoidosis is rare and difficult to diagnose especially in the absence of systemic involvement." | ( Ajjan, M; Grigorian, AA; Walid, MS, 2008) |
| "Sarcoidosis is a granulomatous disease of unknown etiology." | ( Cynowska, B; Drozdowski, J; Porzezińska, M; Poławska, K; Słomiński, JM; Wolska-Goszka, L, 2008) |
| "Sarcoidosis is a systemic disease of unknown etiology that is characterized by chronic non-caseating granulomatous inflammation with tissue destruction." | ( Aihara, Y; Fujinaga, S; Harada, T; Imagawa, T; Ito, S; Nagahama, K; Nakamura, T; Sasaki, T; Yokota, S, 2009) |
| "Sarcoidosis is a systemic granulomatous disease." | ( Bieber, T; Novak, N; Wilsmann-Theis, D, 2008) |
| "Sarcoidosis is a multi-systemic disease that has various dermatologic presentations." | ( Wise, RD, 2008) |
| "Sarcoidosis is a systemic disease and extrapulmonary lesions are also present." | ( Hisada, T; Ishizuka, T; Kaira, K; Mori, M; Sunaga, N; Yanagitani, N, 2008) |
| "Hypothalamic sarcoidosis is a rare entity that can alter the hypothalamic-pituitary axis and induce various combinations of endocrine changes." | ( Afshar, K; Engelfried, K; Sharma, OP, 2008) |
| "Sarcoidosis is a multisystemic inflammatory disorder of unknown etiology." | ( Majithia, V; Saharan, S, 2008) |
| "Sarcoidosis is a granulomatous inflammation of unknown origin that varies in severity and distribution." | ( Cakmak, SK; Gönül, M; Gül, U; Gündüz, H; Han, O; Kulaçoğlu, S, 2009) |
| "Sarcoidosis is a chronic, multisystem granulomatous disease of unknown etiology." | ( Chatziioannou, S; Kolilekas, L; Manali, E; Papiris, S; Rontogianni, D; Triantafillidou, C, 2009) |
| "Sarcoidosis is a systemic granulomatous disease of unknown etiology characterized by activation of macrophages and T lymphocytes." | ( Bargagli, E; Bianchi, N; Mazzi, A; Mezzasalma, F; Olivieri, C; Perrone, A; Pieroni, MG; Prasse, A; Rottoli, P, 2009) |
| "Cutaneous sarcoidosis is challenging to diagnose due to its many nonspecific manifestations." | ( Gottlieb, AB; Kerbleski, JF; Zhang, JX, 2009) |
| "Pleural sarcoidosis is not a rare disease, and some patients with sarcoidosis experience chest pain, although the cause is often unknown." | ( Betsuyaku, T; Hattori, T; Inomata, T; Konno, S; Nasuhara, Y; Nishimura, M, 2009) |
| "Sarcoidosis is a multisystem granulomatous disease that may involve the bone marrow, with resultant fever, anemia, and leukopenia." | ( Callen, JP; Kalajian, AH; Van Meter, JR, 2009) |
| "Sarcoidosis is a multisystem inflammatory disease that can affect the nervous system." | ( Drory, VE; Fahoum, F; Issakov, J; Neufeld, MY, 2009) |
| "Cardiac sarcoidosis is also associated with myocardial granuloma formation and scarring." | ( Alsayed, L; Das, MK; Homsi, M; Mahenthiran, J; Safadi, B, 2009) |
| "MRI findings of sarcoidosis are usually intraparenchymal granuloma with leptomeningeal lesions." | ( Ito, S; Kuwabara, S; Makino, T; Mori, M, 2009) |
| "Sarcoidosis is a multisystem disease of unknown origin." | ( Bargagli, E; Bertelli, P; Gonnelli, S; Olivieri, C; Penza, F; Rottoli, P; Volterrani, L, 2011) |
| "Sarcoidosis is a chronic inflammatory disease, characterized by granulomatous inflammation, prominently involving the respiratory system." | ( Maver, A; Medica, I; Peterlin, B; Salobir, B; Tercelj, M, 2010) |
| "Sarcoidosis is a rare multisystem inflammatory disorder of unknown cause." | ( Butler, CR; Khalil, S; Mace, AD; Nouraei, SA; Sandhu, GS; Sandhu, SK, 2010) |
| "Severe pulmonary sarcoidosis is often complicated by pulmonary hypertension (PH) caused by different pathophysiological mechanisms." | ( Carlsen, J; Iversen, M; Milman, N; Svendsen, CB; Videbaek, R, 2009) |
| "Sarcoidosis is a systemic granulomatous disease with predominant manifestation in the lungs, often presenting as interstitial lung disease." | ( Boros, PW; Borsboom, GJ; Enright, PL; Hyatt, RE; Quanjer, PH; Wesolowski, SP, 2010) |
| "Cardiac sarcoidosis is characterized by a high incidence of complete atrioventricular block, ventricular arrhythmia, and cardiac dysfunction." | ( Kawamoto, M; Kusunoki, S; Miyoshi, H, 2010) |
| "Childhood sarcoidosis is a rare multisystemic disorder that can have variable clinical presentations." | ( Alsubaie, S; Alsultan, A; Khalifah, M; Osman, ME; Othman, S; Raddaoui, E, 2010) |
| "Sarcoidosis is a systemic disorder characterized by the formation of non-caseating granulomas in variable organs." | ( Grutters, JC; Rijkers, GT; Ruven, HJ; Van Den Bosch, JM; Van Moorsel, CH; Veltkamp, M, 2010) |
| "Sarcoidosis is a systemic, clinically heterogeneous disease characterized by the development of granulomas." | ( Baughman, RP; Garcia, JG; Hogarth, K; Jabbar, U; Korsten, P; Niewold, TB; Patterson, K; Sawaqed, R; Sweiss, NJ; Wollman, R, 2010) |
| "Sarcoidosis is increasingly recognized in south India as well." | ( Abraham, MP; Babu, K; Kini, R; Mehta, R; Murthy, KR; Subbakrishna, DK, 2010) |
| "Sarcoidosis is a potentially life-threatening, multisystem, granulomatous disease that can present with cutaneous manifestations in patients." | ( George, DE; Hsu, S; Kelley, BP; LeLeux, TM, 2010) |
| "Spinal cord sarcoidosis is a rare manifestation of sarcoidosis." | ( Sakushima, K; Sasaki, H; Shiga, T; Terae, S; Tsuji-Akimoto, S; Yabe, I; Yashima-Yamada, M, 2011) |
| "Sarcoidosis is a chronic inflammatory disease that involves multiple systems." | ( Tsai, CF; Yang, CC; Yip, PK, 2010) |
| "Sarcoidosis is a chronic inflammatory disorder with an unknown etiology characterized by noncaseating granulomas." | ( Herbort, CP; Mochizuki, M; Papadia, M, 2010) |
| "The aetiology of sarcoidosis is unclear." | ( Fränken, T; Grohé, C; Meyer, R; Nickenig, G; Pabst, S; Schönau, J; Skowasch, D; Stier, S, 2011) |
| "Sarcoidosis is a common disorder with heterogeneous severity." | ( Carton, Z; Dion, G; Freynet, O; Londner, C; Nunes, H; Valeyre, D; Zendah, I, 2011) |
| "Sarcoidosis is a chronic multisystem disease of unknown origin, which is characterized by T-helper-1 (Th1)-mediated immune responses." | ( Asano, Y; Miyagaki, T; Ohno, Y; Saeki, H; Sato, S; Shibata, S; Tamaki, K; Tsunemi, Y, 2011) |
| "Sarcoidosis is an increasingly well-recognised complication of interferon therapy for hepatitis C infection, primarily manifesting with cutaneous or pulmonary involvement." | ( Malhotra, R; Morley, AM; O'Sullivan, E; Thaung, C, 2011) |
| "Sarcoidosis is a disease well known to dermatologists because of the frequency of cutaneous involvement." | ( Bagot, M; Demongeot, C; Flageul, B; Georges, P; Moulonguet, I, 2011) |
| "Gastric sarcoidosis is seen in some 10% of patients with systemic sarcoidosis and is symptomatic in less than 1% of cases." | ( Bagot, M; Demongeot, C; Flageul, B; Georges, P; Moulonguet, I, 2011) |
| "Sarcoidosis is a multisystem granulomatous disease that affects multiple organs in adults between 20 and 50 years old." | ( Jordá, E; López, V; Molina, I; Monteagudo, C, 2011) |
| "Sarcoidosis is an idiopathic systemic granulomatous disease, in which non-caseating granulomas formations can occur in any organ." | ( Lorenzi, S; Misciali, C; Torres, F; Tosti, A, 2011) |
| "Sarcoidosis is a multisystem granulomatous disorder of unknown etiology that typically affects young adults." | ( Rafiei, P; Vijayakumar, V, 2011) |
| "Juvenile sarcoidosis is a rare, chronic, multisystem, granulomatous disease of obscure etiology which is seen in childhood and adulthood." | ( Fretzayas, A; Moustaki, M; Vougiouka, O, 2011) |
| "Sarcoidosis is a granulomatous multisystemic disease of unclear etiology, which can affect any organ." | ( Bertsch, HP; Meyersburg, D; Schön, MP; Seitz, CS, 2011) |
| "Sarcoidosis is a systemic disorder with unknown etiology, characterized by non-caseating granulomas in numerous organs and tissues." | ( Altmann, S; Damert, HG; Mirastschijski, U; Schneider, W; Schreiber, J, 2011) |
| "Sarcoidosis is a rare, often asymptomatic disease." | ( Altmann, S; Damert, HG; Mirastschijski, U; Schneider, W; Schreiber, J, 2011) |
| "Osseous sarcoidosis is relatively uncommon, and treatment with corticosteroids is not always effective." | ( Abe, K; Ebina, M; Gomi, K; Hisata, S; Mitsuishi, Y; Murakami, K; Muramatsu, S; Nara, M; Nukiwa, T; Tamada, T, 2011) |
| "Sarcoidosis is a systemic inflammatory disorder which can mimick other entities and has a vast array of presentations including altered mentation and signs of increased intracranial pressure." | ( Abrams, C; Chapman, R; Omoregie, E; Sarva, H, 2011) |
| "Sarcoidosis is a systemic disease characterized by granulomas." | ( Kanazawa, S; Kunimatsu, K; Murai, O; Naruishi, K; Ogihara, S; Suwa, N; Takeda, Y; Yaegashi, T, 2011) |
| "Sarcoidosis is an inflammatory disease." | ( Ihan, A; Rylander, R; Salobir, B; Simčič, S; Stopinšek, S; Terčelj, M; Wraber, B, 2011) |
| "Renal sarcoidosis is rare and may lead to renal failure in less than 3% of patients." | ( Al Hamany, Z; Bayahia, R; Benamar, L; Ouzeddoun, N; Sadek, BH; Sqalli, Z, 2011) |
| "Sarcoidosis is a multisystemic granulomatous disease of unknown etiology." | ( Fukunaga, T; Imamura, T; Kato, J; Kawano, N; Kawano, S; Kitamura, K; Masuyama, H; Mihara, K; Shimao, Y; Toyoda, K; Ueda, A; Yoshimura, Y, 2012) |
| "Cardiac sarcoidosis is a potentially fatal complication of sarcoidosis." | ( Beanlands, RS; Birnie, D; Dasilva, J; Dekemp, RA; Gulenchyn, KY; Leung, E; Mylonas, I; Nery, P; Wells, GA; Williams, K; Wisenberg, G; Youssef, G, 2012) |
| "Sarcoidosis is an inflammatory disease of unknown etiology associated with the development of granulomatous nodules in various organs, most commonly the lungs, eyes, and skin." | ( Bryant, MG; Buchner, EJ; Eby, SA, 2012) |
| "Sarcoidosis is a multisystem disease related to helper T cell responses." | ( Chinda, J; Fujino, T; Hasebe, N; Kabara, M; Matsuki, M; Nakagawa, N, 2013) |
| "Sarcoidosis is an inflammatory disease characterised by enhanced production of reactive oxygen species and alterations in the circulating lipid profile." | ( Ilić, J; Ivanišević, J; Jelić-Ivanović, Z; Kotur-Stevuljević, J; Spasić, S; Stefanović, A; Videnović-Ivanov, J; Vučinić-Mihailović, V, 2012) |
| "Sarcoidosis is characterised by increased oxidative stress, diminished overall anti-oxidative protection and alterations in the circulating lipid profile." | ( Ilić, J; Ivanišević, J; Jelić-Ivanović, Z; Kotur-Stevuljević, J; Spasić, S; Stefanović, A; Videnović-Ivanov, J; Vučinić-Mihailović, V, 2012) |
| "Sarcoidosis is a chronic, multisystem, granulomatous disease of unknown etiology." | ( Sinacori, JT; Wold, SM, 2012) |
| "Sarcoidosis is a chronic multisystemic granulomatous disease of unknown origin." | ( Burgués Calderón, M; Castellanos González, M; Peralto, JL; Petiti Martin, G; Sanz Bueno, J; Vanaclocha, F; Villar Buil, M, 2012) |
| "Sarcoidosis is a multi-systemic disease, the diagnosis of which depends on the presence of non-necrotising granulomas in a biopsy specimen." | ( Binesh, F; Halvani, H; Navabii, H, 2012) |
| "Sarcoidosis is a rare side effect of interferon therapy that has been reported over the last years." | ( Alves, A; Cardoso, C; Freire, R; Oliveira, A, 2011) |
| "Although HP sarcoidosis is unusual, physicians should be aware that such specific localization could be the first manifestation of sarcoidosis." | ( Androdias, G; Bihan, H; Borson-Chazot, F; Broussolle, C; Brue, T; Cathebras, P; Cotton, F; Langrand, C; Muller, G; Pinede, L; Raverot, G; Seve, P; Valeyre, D; Varron, L, 2012) |
| "Sarcoidosis is a non-caseating, granulomatous, epithelioid inflammation." | ( Kuchai, R; Saleh, HA; Taghi, AS; van Griethuysen, J, 2012) |
| "Sarcoidosis is a multi-system disorder of unknown aetiology characterised by non-caseating granulomatous inflammation with varying presentation and prognosis." | ( Ahsan, H; Fatima, K; Haque, AS; Sheerani, M; Zubairi, AB, 2010) |
| "Sarcoidosis is a multi-system disorder characterized by non-caseating epithelioid granulomas in multiple organs." | ( Ahbap, E; Akgül, C; Arar, AS; Basturk, T; Koc, Y; Ozagarı, A; Sakacı, T; Sevınc, M; Unsal, A, 2013) |
| "Sarcoidosis is an autoimmune disease, and hypothalamic-pituitary-adrenal (HPA) axis activity is blunted in autoimmunity." | ( Dimopoulos, S; Fatouros, IG; Greene, M; Ilias, I; Mastorakos, G; Nanas, S; Paltoglou, G; Papamichalopoulos, A; Pouliou, E, 2013) |
| "Sarcoidosis is a granulomatous disease of unknown aetiology which primarily affects the lungs, but can affect other tissues including the central nervous system (CNS)." | ( Arnold, C; Broadley, SA; Meenakshi, M, 2012) |
| "Sarcoidosis is a non-caseating, granulomatous disease of incompletely understood aetiology that can affect nearly all organs including the liver." | ( Bakker, GJ; Beuers, U; Haan, YC; Maillette de Buy Wenniger, LJ, 2012) |
| "Sarcoidosis is multi organ disease with cutaneous manifestation in 20%-35% patients." | ( Kalafi, A; Vasaghi, A, 2012) |
| "Sarcoidosis is a systematic inflammatory condition with a variable clinical course." | ( Huffstutter, JE; Huffstutter, JG, 2012) |
| "Sarcoidosis is a granulomatous multisystem disease." | ( Aderaye, G; Aleme, M; Atnafu, A; Diro, E, 2011) |
| "Cardiac sarcoidosis is the most important cause of patient mortality in systemic sarcoidosis, yielding a 5-year mortality rate between 25% and 66% despite immunosuppressive treatment." | ( Bruder, O; Bültel, H; Deluigi, CC; Gawaz, M; Gloekler, S; Greulich, S; Grün, S; Kramer, U; Mahrholdt, H; Nassenstein, K; Nothnagel, D; Ong, P; Schneider, S; Schumm, J; Sechtem, U; Wagner, A; Wahl, A; Zürn, C, 2013) |
| "Sarcoidosis is a chronic inflammatory multisystem disease of unknown aetiology." | ( Cacopardo, B; Nunnari, G; Pinzone, MR, 2013) |
| "Sarcoidosis is a granulomatous multisystemic disorder of unknown origin that can affect the kidneys." | ( Eishi, Y; Inoue, Y; Morita, H; Satoh, F; Tayama, H; Yoshimura, A, 2013) |
| "Sarcoidosis is a multiorgan granulomatous disease of unknown etiology that primarily involves the lungs and the lymphatic system." | ( Augier, A; Brillet, PY; Soussan, M; Valeyre, D; Weinmann, P, 2014) |
| "Sarcoidosis is a multisystem disease that commonly affects the lung, eye, skin, and lymphatic systems." | ( Cella, D; Grund, H; Judson, MA; Victorson, DE, 2014) |
| "Sarcoidosis is a chronic granulomatous disease for which there are limited therapeutic options." | ( Aboud, C; Algood, H; Boyd, AS; Braun, N; Burke, VE; Drake, WP; Isom, J; Kaminski, N; King, LE; Oswald-Richter, K; Pandit, KV; Richmond, BW; Taylor, T; Yu, C, 2013) |
| "Sarcoidosis is an idiopathic granulomatous disorder with heterogeneous clinical manifestations and variable prognosis." | ( Eber, CD; Geyer, AI; Hiensch, R; Kraus, T; Moran, TM; Roberts, M; Wisnivesky, J, 2013) |
| "Sarcoidosis is a systemic granulomatous disease of unknown etiology that involves many organs, occasionally mimicking malignancy." | ( Han, EJ; Jang, YS; Kang, S; Kim, HS; Lee, IS; Lee, JM, 2013) |
| "Gingivitis due to sarcoidosis is a relatively rare condition." | ( Aslan, K; Aydın, D; Gören, F; Güzel, A; Karagöz, F; Köksal, N, 2013) |
| "Many patients with sarcoidosis are chronically dependent on steroids and there is limited data on the use of steroid-sparing agents." | ( DeVita, MV; Michelis, MF; Rosenstock, JL; Zaidi, AA, 2015) |
| "Childhood sarcoidosis is a rare granulomatous disorder that affects several systems including the lungs, skin, eyes, and bones." | ( Chababi, M; El Sayed, F; Torbey, G; Youssef, H, 2013) |
| "Sarcoidosis is a systemic, granulomatous disease that can affect multiple organs and has a variable clinical course." | ( Deneer, VH; Grutters, JC; van Moorsel, CH; Vorselaars, AD, 2013) |
| "Sarcoidosis is a systemic granulomatous disease, which is thought to result from an aberrant immune response." | ( Huang, H; Jiang, C; Liu, J; Lu, Z; Wang, Y; Xu, Z, 2013) |
| "Sarcoidosis is a multisystem granulomatous disease of unknown etiology, with prevalence ranging from 1 to 50 per 100,000." | ( Irwin, RW; Mattie, R, 2014) |
| "Sarcoidosis is a systemic granulomatous disease of unknown etiology." | ( Bengel, FM; Schatka, I, 2014) |
| "Sarcoidosis is a systemic granulomatous disease of unknown origin." | ( Aki, S; Aoyagi, M; Arai, Y; Hirasawa, S; Inaba, N; Tamura, T; Tanaka, H; Tsuura, Y, 2013) |
| "Sarcoidosis is a systemic granulomatous disease that most commonly involves the lung and thoracic lymph nodes." | ( Ben Hassine, L; Cherif, E; Kechaou, I; Khalfallah, N, 2013) |
| "Sarcoidosis is a multisystem inflammatory disorder of unknown cause which can affect any organ system." | ( Deegan, AP; Garvey, JF; McCarthy, C; McDonnell, TJ, 2013) |
| "Sarcoidosis is a multisystemic disease, which may affect almost any organ including the eyes." | ( Bhattacharya, A; Gupta, D; Jung, RS; Kumar, R; Maturu, NV; Mittal, BR, 2014) |
| "Sarcoidosis is a rare, systemic disease that is characterized by the formation of granulomas in various organs, including the skin." | ( Karagiannidis, I; Lippert, U; Zouboulis, CC, 2014) |
| "Sarcoidosis is characterized by a wide range of disease manifestations." | ( Cremers, JP; Drent, M; Koek, GH; Mostard, RL; Van Kroonenburgh, MJ; Vöö, SA; Wijnen, PA, 2014) |
| "Cardiac sarcoidosis is most commonly found in the left ventricular (LV) free wall." | ( Magota, K; Manabe, O; Masuda, A; Nishimura, M; Ohira, H; Oyama-Manabe, N; Sato, T; Tamaki, N; Tsujino, I; Yamada, A; Yoshinaga, K, 2014) |
| "Sarcoidosis is a pleomorphic disease that can present with pulmonary hypertension (PH)." | ( Baloira Villar, A; Núñez Fernández, M; Pousada Fernández, G; Valverde Pérez, D, 2015) |
| "Cardiac sarcoidosis is often not recognized antemortem, as sudden death may be the presenting feature." | ( Bradfield, J; Fishbein, M; Hwang, J; Lynch, JP; Shivkumar, K; Tung, R, 2014) |
| "Sarcoidosis is an ordinary systemic inflammatory disease that can affect many organs." | ( Hermanrud, T; Janner, JH; Steffensen, IE, 2014) |
| "Early onset sarcoidosis is a rarely reported disease in children." | ( Arya, A; Azad, C; Goyal, S; Mahajan, V, 2014) |
| "Sarcoidosis is an important differential diagnosis in young children with joint and salivary gland involvement." | ( Arya, A; Azad, C; Goyal, S; Mahajan, V, 2014) |
| "Sarcoidosis is an inflammatory disease with increased levels of inflammatory cytokines." | ( Ihan, A; Rylander, R; Salobir, B; Simčič, S; Stopinšek, S; Terčelj, M, 2014) |
| "Sarcoidosis is a chronic systemic disease of unknown etiology that is characterized by the presence of noncaseating epithelioid granulomas, usually in multiple organs." | ( Akasaka, T; Imanishi, T; Orii, M, 2014) |
| "Cardiac sarcoidosis is present in 25 % of all sarcoidosis but only causes clinical problems in 5 % of them." | ( Judson, MA, 2015) |
| "Sarcoidosis is a systemic inflammatory disease usually presenting with pulmonary symptoms." | ( Snijders, GF; Sprong, T, 2014) |
| "Cardiac sarcoidosis is an infiltrative, granulomatous inflammatory disease of the myocardium." | ( Argüder, E; Baştuğ, S; Hasanoğlu, HC; Karabekir, E; Karalezli, A; Maraş, Y; Öğüt, T; Şentürk, A, 2015) |
| "Sarcoidosis is a multisystem disease of unknown origin." | ( Bayram, M; Erdoğan, EB; Özçelik, HK; Özkan, D; Sezer, M; Tabak, L; Yakar, A; Yakar, F, 2015) |
| "Sarcoidosis is a multisystem granulomatous disease that affects 10 to 20 people per 100,000 in the United States." | ( Braun, MM; Hermann, S; Layton, M; Overbeek-Wager, E; Petersen, K; Trowbridge, D, 2015) |
| "Childhood sarcoidosis is prevalent in Louisiana." | ( Dimitriades, VR; Espinoza, LR; Gedalia, A; Khan, TA; Shetty, AK, 2016) |
| "Sarcoidosis is a chronic systemic disease of unknown origin and uncertain prognosis that most commonly affects young adults, and frequently presents with bilateral hilar lymphadenopathy, pulmonary infiltrates and ocular and skin lesions." | ( Spagnolo, P, 2015) |
| "Sarcoidosis is a chronic multisystem granulomatous inflammatory disorder." | ( George, G; Kirresh, O; Schofield, J, 2015) |
| "Symptoms of sarcoidosis are not specific and can be markedly different according to organ involvement and disease course." | ( Bonella, F; Costabel, U; Wessendorf, TE, 2015) |
| "Sarcoidosis is a multisystem granulomatous disorder of unknown aetiology characterised pathologically by the presence of non-caseating granulomas in involved organs." | ( Iqbal, N; Irfan, M; Mahmood, A; Minhas, K, 2015) |
| "Sarcoidosis is a major cause of ocular or periocular inflammation." | ( Al-Hussain, H; Alabiad, C; Alkatan, H; Choi, D; Czyz, CN; Dailey, RA; Dolman, P; Dubovy, S; Edward, DP; Foster, JA; Grossniklaus, HE; Harrington, CA; Harris, GJ; Kazim, M; Kikkawa, D; Korn, BS; Ng, JD; Parekh, P; Patel, P; Planck, SR; Rosenbaum, JT; Selva, D; Sibley, CH; Stauffer, P; Steele, EA; Tse, D; White, V; Wilson, DJ; Yeatts, RP, 2015) |
| "Sarcoidosis is a multisystem disease characterized by non-caseating granulomas present in the involved organ systems." | ( Argraves, M; Dadras, SS; Sloan, SB, 2015) |
| "Sarcoidosis is a multiorgan disease with no single etiology." | ( Nair, N; Narula, J; Patrick, H, 2015) |
| "Sarcoidosis is a multisystem granulomatous disorder with a high prevalence of cardiac involvement." | ( Aggarwal, NR; Chareonthaitawee, P; Cooper, LT; Gersh, BJ; Snipelisky, D; Young, PM, 2015) |
| "Whereas cutaneous sarcoidosis is present in up to one-third of cases and may present with a wide variety of lesions, our presentation is uncommon." | ( Benchikhi, H; Chiheb, S; Elfatoiki, FZ; Jabri, L; Soussi, W, 2015) |
| "Cardiac sarcoidosis is one of the most serious and unpredictable aspects of this disease state." | ( Dubrey, SW; Mittal, T; Sharma, R; Underwood, R, 2015) |
| "Sarcoidosis is a chronic disease characterised by formation of non-calcified granulomas." | ( Karaarslan, AA; Kobak, Ş; Sever, F; Yilmaz, H, 2015) |
| "Sarcoidosis is an idiopathic inflammatory disorder characterized by noncaseating granulomas, which can affect any organ system." | ( Paauw, DS; Shinn, J, 2015) |
| "Sarcoidosis is a multisystem granulomatous disorder, most frequently involving the lungs, skin, or eyes." | ( Baarsma, GS; Dalm, VA; Dik, WA; Kamphuis, LS; Kwekkeboom, DJ; Missotten, TO; Timmermans, WM; van Daele, PL; van Hagen, PM; van Laar, JA, 2015) |
| "Sarcoidosis is a disease of unknown cause histologically characterized by non-caseating granulomas that can involve any organ or tissue." | ( Fontana, NP; Melero, OM; Navarro, EJ; Palacios, SL, 2015) |
| "Sarcoidosis is a systemic granulomatous disease that affects numerous organs, commonly manifesting at the lungs and skin." | ( Amber, KT; Bloom, R; Hertl, M; Mrowietz, U, 2015) |
| "Sarcoidosis is a systemic disease characterized by the formation of non-caseating granulomas in multiple organs." | ( Higashi, T; Kariyama, K; Kishida, M; Nishimura, M; Nouso, K; Wada, N; Wakuta, A, 2015) |
| "Sarcoidosis is an idiopathic inflammatory disorder characterized by the presence of non-caseating tissue granulomas most commonly affecting lungs, lymph nodes and skin." | ( Al-Ani, Z; Macphie, E; Oh, TC; Woodruff, MJ, 2015) |
| "The sarcoidosis is a systemic granulomatosis affecting most frequently the lungs and the mediastinum." | ( Kheder, A; Mahfoudhi, M; Mamlouk, H; Turki, S, 2015) |
| "Sarcoidosis is an inflammatory disease characterized by excessive oxidative stress." | ( Ivanišević, J; Jelić-Ivanović, Z; Kotur-Stevuljević, J; Spasić, S; Stefanović, A; Videnović Ivanov, J; Vučinić Mihailović, V, 2016) |
| "Sarcoidosis is a chronic granulomatous disease." | ( Berdeli, A; Goksel, Ö; Goksel, T; Kobak, S; Orman, M; Sever, F, 2016) |
| "Bone sarcoidosis is rare manifestation of disease usually accompanied with pulmonary involvement." | ( Artiko, V; Grozdic Milojevic, I; Odalovic, S; Saranovic, D; Sobic-Saranovic, D; Videnovic-Ivanov, J, 2016) |
| "Sarcoidosis is a disease which still has uncertain etiology." | ( Bottino, CB; D'Acri, AM; Guimarães, TF; Lima, RB; Martins, CJ; Pereira, EG, 2016) |
| "Sarcoidosis is an inflammatory disorder of unknown etiology that can involve the heart." | ( Bokhari, S; Chen, J; DeLuca, A; Morgenstern, R; Weinberg, RL, 2017) |
| "Sarcoidosis is a multisystemic disease of unknown etiology." | ( Baunacke, A; Hansel, G; Wollina, U, 2016) |
| "Sarcoidosis is a multisystem inflammatory disease that manifests as noncaseating granulomas, commonly in the lungs and intrathoracic lymph nodes." | ( Aksan, T; Basat, SO; Ceran, F; Ozturk, MB, 2016) |
| "Sarcoidosis is a well-recognized systemic granulomatous process which involves the central nervous system in 5-15% of patients." | ( Prayson, RA, 2016) |
| "Sarcoidosis is a systemic disease of unknown aetiology." | ( Bonella, F; Costabel, U; Wessendorf, TE, 2017) |
| "Sarcoidosis is a systemic disorder of unknown etiology." | ( Bernt, R; Haller, J; Hergan, K; Mirzaei, S; Zandieh, S, 2018) |
| "Sarcoidosis is an inflammatory disease with multisystem involvement characterized by the presence of noncaseating granulomas." | ( Aggarwal, HK; Dabas, G; Jain, D; Mittal, A, 2016) |
| "Sarcoidosis is a chronic granulomatous disease that can affect multiple organs." | ( Arai, S; Hayashi, Y; Hirata, K; Ishii, Y; Kurasawa, K; Machida, Y; Nagasawa, J; Ohmi, F; Okada, H; Sada, T; Senoh, T; Suzuki, S; Takemasa, A; Umetsu, T, 2016) |
| "Sarcoidosis is a systemic non caseous granulomas disease." | ( Ayadi, S; Bougassas, W; Cheikh, M; Ennaifer, R; Hadj, NB; Nejma, HB; Romdhane, H, 2016) |
| "If cardiac sarcoidosis is suspected, early diagnosis and risk stratification of ventricular arrhythmia are important." | ( Inoko, M; Nakane, E; Nakasone, K; Sekihara, T, 2016) |
| "Sarcoidosis is a chronic, systemic, inflammatory disorder that is characterized by the formation of noncaseating granulomas." | ( Al-Qudah, ZA; Souayah, N; Yacoub, HA, 2016) |
| "Sarcoidosis is a systemic disease of unknown etiology characterized by the development of non-caseating epitheloid granulomas." | ( Baughman, RP; Brito-Zerón, P; Pallarés, L; Pérez-Alvarez, R; Ramos-Casals, M; Retamozo, S, 2016) |
| "Sarcoidosis is a multi-system disease characterized by the presence of non-caseating epithelioid granulomas in affected tissues, including skeletal muscle." | ( Eutsler, E; Ferguson, C; Kitcharoensakkul, M; Orandi, AB; White, AJ, 2016) |
| "Sarcoidosis is an idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis which involve various organs." | ( Abgral, R; Benigni, P; Feger, B; Robin, P; Salaun, PY, 2016) |
| "As such, laryngeal sarcoidosis is associated with significant morbidity and mortality, requiring a high index of suspicion for timely diagnosis and treatment." | ( Gulati, M; Herzog, EL; Homer, R; Pan, H; Ryu, C, 2017) |
| "Skin lesions in sarcoidosis are often the initial symptoms that enable the dermatologist to be the first to diagnose this granulomatosis." | ( Kambe, N; Kishimoto, I; Okamoto, H; Thi Hong Nguyen, C; Ueda-Hayakawa, I, 2017) |
| "Sarcoidosis is a multisystem disease with frequent cardiac involvement, albeit manifest cardiac disease is rare." | ( Boga, S; Caliskan, M; Demircioglu, K; Guvenc, TS; Kanbay, A; Kavas, M; Kul, S; Kutlu, GA; Yakar, HI; Yilmaz, Y, 2017) |
| "Sarcoidosis is a systemic inflammatory disease characterized by non-necrotizing granulomas in involved organs, most commonly the lung." | ( Arger, NK; Benn, BS; Gelfand, JM; Gomez, A; Ho, M; Kidd, SA; Koth, LL; Lehman, Z; Nguyen, CP; Ramstein, J; Su, R; Sun, S, 2017) |
| "Sarcoidosis is a multisystem granulomatous disease of unknown etiology that rarely presents in childhood." | ( Downie, ML; Fuchs, S; Hebert, D; John, R; Lim, L; Mulder, J; Noone, DG; Schneider, R; Tehrani, N; Wasserman, JD, 2018) |
| "Sarcoidosis is primarily a disease of the lungs and reticuloendothelial system; however, the prevalence of renal involvement with sarcoidosis may be under-recognized." | ( Chacko, B; Lea-Henry, T; Rajkumar, T, 2018) |
| "Sarcoidosis is a major cause of granulomatous uveitis but rarely manifests as multiple choroidal granulomas." | ( Ishihara, M; Mizuki, N; Shibuya, E; Tanaka, S, 2018) |
| "Sarcoidosis is an inflammatory disorder of immune dysregulation characterized by non-caseating granulomas that can affect any organ." | ( Chu, G; Chung, T; Hunyor, I; Kane, A; Limaye, S; Murad, A; Riminton, S; Russo, R; Sasson, SC; Williamson, J, 2017) |
| "Sarcoidosis is associated with cell-mediated immunodeficiency and treatment of symptomatic sarcoidosis usually includes systemic immunosuppressants." | ( Biard, L; Bodaghi, B; Cacoub, P; Chapelon, C; Domont, F; Duréault, A; Pourcher, V; Rigon, MR; Saadoun, D; Savey, L, 2017) |
| "Sarcoidosis is a systemic inflammatory disease which can involve nearly any organ." | ( Beanlands, RSB; Birnie, DH; de Kemp, RA; Juneau, D; Leung, E; Nery, P; Russo, J, 2018) |
| "Sarcoidosis is a chronic granulomatous inflammatory disease that commonly causes lung disease, but can affect other vital organs and tissues." | ( Crouser, ED; Le, V, 2018) |
| "Sarcoidosis is a highly variable, systemic granulomatous disease of hitherto unknown aetiology." | ( Bargagli, E; Bonella, F; Bresser, P; Costabel, U; Crawshaw, A; Donnelly, S; Dubaniewicz, A; Filipovic, S; Fischer, A; Freitag-Wolf, S; Gaede, KI; Grah, C; Grohé, C; Grubanovic, A; Günther, A; Haraldsdottir, SO; Ho, LP; Homolka, J; Jochens, A; Jonkers, R; Jorundsdottir, KB; Jovanovic, D; Kadija, Z; Keane, MP; Kendrick, Y; Kieszko, R; Kolek, V; Krawczak, M; Luisetti, M; Marshall, B; Mihailović-Vučinić, V; Milanowski, J; Millar, A; Müller, A; Müller-Quernheim, J; O'Beirne, S; O'Reilly, K; Olivieri, C; Pabst, S; Peroš-Golubičić, T; Petrek, M; Pfeifer, M; Poletti, V; Prasse, A; Rottoli, P; Schnerch, J; Schreiber, S; Schupp, JC; Slováková, A; Spencer, L; Sterclova, M; Strausz, J; Tittmann, L; Valeyre, D; Vašáková, M; Videnovic-Ivanovic, J; Wallaert, B; Weihrich, A; Wirtz, H; Wuyts, W; Zabel, P, 2018) |
| "Sarcoidosis is a granulomatous disease of unknown etiology." | ( Kempisty, A; Kuś, J; Lewandowska, A, 2018) |
| "If cardiac sarcoidosis is part of biopsy-confirmed systemic sarcoidosis, the diagnosis can be based on cardiac imaging studies." | ( Haarala, A; Kähönen, M; Nikus, K; Sipilä, K; Tikkakoski, A; Tuominen, H, 2020) |
| "Sarcoidosis is a multisystem disease of unknown aetiology with pulmonary involvement in most patients." | ( Cehajic Kapetanovic, J; Jones, NP; Steeples, LR, 2018) |
| "Sarcoidosis is a multisystem condition which may affect a number of organs and, within the cardiopulmonary system, most commonly manifests as parenchymal, airway-centred, nodal, vascular or cardiac disease." | ( Desai, SR; George, PM; Polkey, MI; Rice, A; Shanks, AM; Thomas, SR, 2018) |
| "Sarcoidosis is a chronic, inflammatory disease with unknown cause characterized by non-caseating granuloma formations." | ( Kobak, S; Semiz, H; Yalcin, M, 2018) |
| "Sarcoidosis is a rare, multisystem granulomatous disease of incompletely understood pathogenesis." | ( Konig, MF; Korsten, P; Nikiphorou, E; Tampe, B, 2018) |
| "Cutaneous sarcoidosis is not an uncommon disorder, and the skin can be the sole manifestation in about 10% of patients." | ( Didona, D; Donati, M; Donati, P; Panetta, C; Paolino, G, 2017) |
| "Neurosarcoidosis is relatively rare and has diverse manifestations." | ( Guo, D; Jia, J; Liu, Z; Wang, F; Wei, C; Zhou, A, 2018) |
| "Sarcoidosis is a systemic granulomatous disease including heart (cardiac sarcoidosis, CS)." | ( Abe, S; Ishida, T; Kanno, Y; Kiko, T; Kobayashi, A; Misaka, T; Miyata-Tatsumi, M; Oikawa, M; Takeishi, Y; Yokokawa, T; Yoshihisa, A, 2018) |
| "Sarcoidosis is a rare condition among native Saudis." | ( Alrabee, HA; Alzahrani, M; Estaitieh, OM; Ibrahim, IA, 2018) |
| "BACKGROUND Sarcoidosis is a systemic disease that can affect any organ, including the liver." | ( Bhandari, B; Gao, JZ; Ibrahim, AM; Mamillapalli, CK; Quader, Z; Shuster, D; Soriano, PK, 2018) |
| "Sarcoidosis is a systematic, granulomatous disease of unknown cause which can affect any organ in the body." | ( Bacha, S; Chabbou, A; Chaouch, N; Cheikhrouhou, S; Habibech, S; Ladeb, MF; Racil, H; Sghaier, A, 2018) |
| "Sarcoidosis is a granulomatous condition that has a highly variable presentation." | ( Cook, C; Demaree, E; Powers, J; Prohaska, J, 2018) |
| "Sarcoidosis is a multisystemic granulomatous disease with rare renal involvement." | ( Menezes, M; Patarata, E, 2018) |
| "Sarcoidosis is a chronic granulomatous disease of unknown aetiology with a variable clinical course and prognosis." | ( Fowler, SJ; Fraser, W; Hayton, C; Peel, A; Terrington, DL; Wilson, AM, 2019) |
| "Sarcoidosis is a systemic granulomatous disease with unknown etiology." | ( Bargagli, E; Bergantini, L; Bianchi, F; Cameli, P; Fui, A; Mazzei, MA; Rottoli, P; Sestini, P, 2019) |
| "Sarcoidosis is a granulomatous disease histologically characterized by naked granulomas in various mammals." | ( Imai, A; Imanishi, I; Iyori, K; Kinoshita, M; Shirota, K, 2019) |
| "Sarcoidosis is a rare multisystem chronic inflammatory disease in children." | ( Gomes, MAF; Lima, CBF; Lobo, FPD; Luz, KG; Medeiros, LLC; Monteiro, MGL; Wanderley, NRS, 2019) |
| "The aetiology of sarcoidosis is not well established." | ( Andersson, M; Järvholm, B; Jonsson, E, 2019) |
| "Sarcoidosis is a multisystemic disorder of unknown cause characterized by immune granuloma formation in the involved organs." | ( Aikawa, T; Anzai, T; Furuya, S; Koyanagawa, K; Kuzume, M; Manabe, O; Naya, M; Ohira, H; Oyama-Manabe, N; Tsujino, I, 2021) |
| "Sarcoidosis is a multisystem granulomatous inflammatory disorder frequently affecting the lungs, but also the liver, along with cirrhosis and portal hypertension occurring in less than 1% of the patients." | ( Bilir, M; Tetikkurt, C; Yanardag, H, 2019) |
| "Neurosarcoidosis is a rare inflammatory neurological condition." | ( Amoura, Z; Cohen Aubart, F; Galanaud, D; Haroche, J; Pineton de Chambrun, M, 2020) |
| "Sarcoidosis is a systemic disorder affecting multiple organs." | ( Akbari, R; Ranae, M; Shahani, M, 2019) |
| "Sarcoidosis is a rare multisystem disorder of unknown aetiology characterised by non-caseating granulomas in involved organs; it is a diagnosis of exclusion." | ( Hall, D; Hendriks, T; Leahy, TW; Leedman, SR, 2020) |
| "Sarcoidosis is an unknown etiology multisystem inflammatory disease in which noncaseating granulomas (a collections of inflammatory cells) form and grow in various organs, involving predominantly lungs, intrathoracic lymph node, skin and eyes." | ( Maccarone, MT, 2019) |
| "Sarcoidosis is a multisystem granulomatous disease with a neglected but high prevalence of life-threatening cardiac involvement." | ( Bianco, F; Bucciarelli, V; Caulo, M; Donato Aquaro, G; Gallina, S; Grigoratos, C; Mantini, C; Mastrodicasa, D; Raffaele Cotroneo, A; Ricci, F; Tana, C, 2019) |
| "Sarcoidosis is a multisystem granulomatous disorder of unknown origin characterized by nonspecific clinical symptomatology." | ( Altini, C; Cimino, A; Fanelli, M; Ferrari, C; Niccoli Asabella, A; Rubini, G, 2019) |
| "Sarcoidosis is a systemic granulomatous disease whose etiology has not yet been clarified." | ( Lepiorz, M; Pfeifer, M, 2020) |
| "Osseous sarcoidosis is a very rare presentation, and little information regarding treatment with TNF inhibitors is available." | ( Al-Shyoukh, A; Alawneh, D; Edrees, A, 2020) |
| "Sarcoidosis is a chronic inflammatory disease characterized by non-caseating granuloma which etiology is unknown yet." | ( Akyildiz, M; Atabay, T; Gokduman, A; Kobak, S; Semiz, H; Vural, H, 2020) |
| "As prognosis in sarcoidosis is determined by cardiac involvement, the objective was to study the added value of cardiovascular magnetic resonance (CMR) in risk stratification." | ( Bogaert, J; Degtiarova, G; Dresselaers, T; Flamée, L; Gheysens, O; Symons, R; Van Cleemput, J; Wuyts, W, 2020) |
| "Sarcoidosis is a systemic disease of unknown origin." | ( Ballas, ET; Kalamara, EI; Panagiotidou, ES, 2020) |
| "Sarcoidosis is a granulomatous multisystemic disease of unknown cause most often affecting the lungs, lymph nodes of the pulmonary hilus, eyes, skin, and other structures including central (CNS) or peripheral nervous system (PNS)." | ( Kalmárová, K; Kurča, E; Michalik, J; Nosáľ, V; Plank, L; Sivák, Š; Šutovský, J; Vyšehradský, R; Zeleňák, K, 2019) |
| "Sarcoidosis is a systemic granulomatous disease of unknown etiology that occurs worldwide and is characterized by granuloma formation in different organs." | ( Bauerfeld, C; Luca, F; Pique-Regi, R; Samavati, L; Sendler, E; Talreja, J, 2020) |
| "Sarcoidosis is a systemic granulomatous disease of unknown etiology." | ( Allen, TL; Bhargava, M; Cogswell, RJ; Perlman, DM; Peterson, EJ; Roukoz, H; Shenoy, C; Steinberger, DJ; Te, HS; Zhang, L, 2020) |
| "Genitourinary sarcoidosis is an uncommon entity, and testicular sarcoidosis is even rarer." | ( Kumar, A; Mitra, S; Muthu, GS; Parida, GK; Suman, A, 2020) |
| "Sarcoidosis is a multisystem inflammatory disorder and can affect any organ; however, ureteric involvement is extremely rare with only four cases reported in the literature to date, all of which were diagnosed with surgical ureteral resection including a nephroureterectomy." | ( Hagiwara, K; Hayashida, M; Nagamoto, S; Ogawa, K; Okaneya, T; Sakaguchi, K; Sawa, N; Urakami, S; Yano, A, 2020) |
| "Sarcoidosis is a complex granulomatous disease of unknown cause." | ( Bonella, F; Grunewald, J; Miedema, JR; Spagnolo, P, 2020) |
| "Hypercalcemia in sarcoidosis is usually due to increased activity of 1α-hydroxylase in macrophages of pulmonary granulomata, resulting in low levels of 25-hydroxyvitamin D and high levels of calcitriol." | ( Lower, EE; Zhou, Y, 2020) |
| "Sarcoidosis is one of the leading causes of inflammatory eye disease." | ( El Jammal, T; Gerfaud-Valentin, M; Jamilloux, Y; Kodjikian, L; Sève, P; Tilikete, C, 2020) |
| "Sarcoidosis is a systemic granulomatous disease of unknown etiology." | ( Castro, MDC; Pereira, CAC, 2020) |
| "Sarcoidosis is a systemic disorder of unknown etiology characterized by development of noncaseating granulomas in more than 1 organ system." | ( Jeeva, G; Santhosh, S; Thirumalairaj, R, 2021) |
| "Sarcoidosis is an autoinflammatory disease characterized by the diffusion of granulomas in the lungs and other organs." | ( Calender, A; Israel-Biet, D; Pacheco, Y; Valeyre, D, 2020) |
| "Sarcoidosis is a systemic granulomatous disease with a high prevalence of cardiac involvement in autopsic studies." | ( Cuspidi, C; Milojevic, B; Milojevic, IG; Saeed, S; Tadic, M, 2021) |
| "Sarcoidosis is a rare disease characterized by granulomatous inflammation in affected organs, primarily in lungs." | ( Demircioglu, S; Korkmaz, C, 2020) |
| "Sarcoidosis is a systemic inflammatory disease causing non-caseous granulomatous reactions." | ( Boutros, A; Cecchi, F; Giusti, F; Guadagno, A; Murdaca, G; Queirolo, P; Schiavi, C; Spagnolo, F; Tanda, ET, 2020) |
| "Sarcoidosis is often accompanied by an elevated ACE level." | ( Schwendinger, M; Tarnutzer, AA; Wollmach, AD; Zehnder, D, 2020) |
| "Sarcoidosis is a chronic granulomatous disease of unknown etiology." | ( Bilgic, S; Bilgin, S; Bilir, M; Kubat, B; Sayman, BH; Tetikkurt, C; Tetikkurt, S; Yanardag, H, 2020) |
| "Subcutaneous sarcoidosis is a rare variation and its diagnosis requires a high index of suspicion." | ( Fahim, S; Ghanadan, A; Izadi Firouzabadi, L; Sadeghinia, A, 2021) |
| "Sarcoidosis is characterised by the formation of noncaseating granulomas classically affecting lungs, lymph nodes and skin." | ( Case, R; Kalra, S; Patel, D; Patel, V, 2021) |
| "Sarcoidosis is a systemic condition characterized by formation of granulomas that can involve many organ systems, with the lungs and intrathoracic lymph nodes involved in more than 90% of cases." | ( Falk, N; Garland, S; Wilk, A, 2021) |
| "Sarcoidosis is a chronic, multisystem disorder." | ( Azza, O; Suz, CS; Tan, WJ; Zuki, M, 2021) |
| "Bone sarcoidosis is usually considered a rare manifestation of multisystemic sarcoidosis." | ( Cornelis, L; De Meester, L; De Scheerder, MA; Van Dorpe, J, 2022) |
| "Sarcoidosis is pathologically characterized by the formation of non-necrotizing epithelioid cell granulomas." | ( Hara, M; Iwakami, N; Iwakami, SI; Matsuda, H; Miyashita, Y; Takahashi, K, 2021) |
| "Silicosis and sarcoidosis are two very distinct entities in the literature." | ( Forest, F; Froudarakis, M; Gay, P; Pointel, S; Tiffet, O; Trouillon, T; Vergnon, JM, 2021) |
| "Sarcoidosis is an autoimmune multisystem granulomatous disorder of unknown aetiology, which mainly affects the adults in the age group of 20-39 years." | ( Chauhan, A; Jandial, A; Mishra, K; Sandal, R, 2021) |
| "Sarcoidosis is an important member of the family of granulomatous lung diseases." | ( Oliver, LC; Zarnke, AM, 2021) |
| "Sarcoidosis is a multisystem granulomatous disorder that can potentially involve any organ." | ( Agrawal, T; Al-Mallah, M; Alnabelsi, TS; Bhimaraj, A; Kassi, M; Khan, M; Saleh, Y; Sukkari, MH, 2022) |
| "Sarcoidosis is a complex multisystemic disease characterized by noncaseating granulomas affecting mainly the pulmonary system, with cutaneous manifestation in 25% to 30% of cases." | ( Al-Bakkar, LA; Al-Zoubi, NA; Gharaibeh, LM; Hamouri, S; Shatnawi, NJ, 2023) |
| "Isolated lymph node sarcoidosis is uncommon, and the reported usual sites are lymph nodes in the head and neck." | ( Divyateja, H; Gouni, R; Ilerhunmwuwa, NP; Thayyil, S, 2021) |
| "Neurosarcoidosis is a rare disease and is often difficult to diagnose." | ( Asano, M; Fuwa, M; Ikeda, T; Kanayama, T; Kato, A; Mori, I; Morita, H; Shizui, N; Taguchi, K; Tateyama, S, 2022) |
| "Sarcoidosis is rare in children." | ( Chotalia, P; Pandya, S; Srivastava, P, 2022) |
| "Sarcoidosis is a systemic inflammatory disease characterized by the formation of noncaseating epithelioid granulomas." | ( Hashimoto, A; Hisahara, S; Kouzu, H; Koyama, M; Miura, T; Muranaka, A; Nagano, N; Nishikawa, R; Noto, T; Ogawa, T; Shimohama, S; Yano, T, 2021) |
| "Sarcoidosis is an idiopathic granulomatous disease that primarily affects the lungs." | ( Lin, NW; Maier, LA, 2022) |
| "Sarcoidosis is a chronic granulomatous disease that develops with non-caseified granuloma formation." | ( Akyildiz, M; Atabay, T; Gokduman, A; Kobak, S; Vural, H, 2021) |
| "Sarcoidosis is a multisystem disease usually affecting the chest, hilar lymph nodes, and lungs, but can potentially involve any organ; therefore, its clinical presentation may vary." | ( Casavola, M; Foà, A; Golfieri, R; Pizzi, C; Renzulli, M, 2021) |
| "Sarcoidosis is a multisystem granulomatous disease that can affect almost any organ including the skin, liver, ocular, cardiac, renal, nervous, musculoskeletal and endocrine systems." | ( Byrne, B; Field, S; Goh, A; Izham, NF; Porter, E, 2022) |
| "Sarcoidosis is a systemic inflammatory disease, characterised by granuloma formation upon an unknown trigger in genetically predisposed individuals." | ( Böni, C; Brutsche, M; Daccord, C; Distler, O; Elsener, D; Franzen, DP; Funke-Chambour, M; Gruner, C; Hayward-Könnecke, H; Hostettler, KE; Kolios, AGA; Kündig, T; Nilsson, J; Ribi, C; Seebach, JD; Seeger, H; Vrugt, B, 2022) |
| "Sarcoidosis is a multisystem inflammatory disorder with an unknown origin." | ( Bazoukis, G; Efremidis, M; Gounopoulos, P; Konstantinidou, E; Lakoumentas, I; Letsas, KP; Liatakis, I; Papadatos, SS; Saplaouras, A; Sideris, A; Tse, G; Vassiliou, VS; Vlachos, K, 2022) |
| "Spinal cord sarcoidosis is a rare manifestation of sarcoidosis with a consequent risk of neurologic sequelae for the patient." | ( André, M; Antoine, JG; Auvens, C; Berthoux, E; Bonnotte, B; Camdessanche, JP; Chapelon-Abric, C; Delboy, T; Desbois, AC; Dufour, JF; Durel, CA; Gavoille, A; Joubert, B; Le Guenno, G; Marignier, R; Moreau, T; Ruivard, M; Saadoun, D; Sève, P; Turcu, A, 2022) |
| "Sarcoidosis is a multisystemic granulomatous inflammation associated with Th17/regulatory T cell (Treg) polarization." | ( Dai, Q; Ding, J; Gao, Q; Gui, X; Liu, X; Ma, C; Meng, K; Wen, Y; Zhang, B; Zhao, Q, 2022) |
| "Sarcoidosis is a multisystem granulomatous disease affecting the nervous system in 3%-5% of cases." | ( Bou, GA; Castilho, AJ; Garcia-Santibanez, R; Hutto, SK, 2022) |
| "Sarcoidosis is a benign systemic granulomatous disorder of unknown etiology." | ( Daimaru, Y; Kajitani, K; Kawamura, S; Koi, Y; Kondo, T; Ohara, M; Oride, Y; Sasada, T, 2022) |
| "Sarcoidosis is an idiopathic inflammatory disorder that is commonly treated with glucocorticoids." | ( Ayasun, R; Bosenberg, M; Clark, A; Daccache, J; Damsky, W; Fazzone-Chettiar, R; Flavell, RA; Gulati, M; Homer, R; Kim, DJ; King, B; McGeary, MK; Miller, EJ; Murphy, MJ; Odell, ID; Pucar, D; Ryu, C; Singh, K; Wang, A; Young, BD, 2022) |
| "Sarcoidosis is a systemic inflammatory disease of unknown etiology, which can affect almost any organ." | ( Fingrova, Z; Habasko, J; Havranek, S; Kuchynka, P; Kysperska, K; Lambert, L; Masek, M; Navratova, L; Palecek, T; Roblova, L; Slovakova, A, 2022) |
| "Sarcoidosis is a multisystem idiopathic granulomatous disorder characterized by the development of noncaseating infiltrative granulomas in various body organs." | ( Aboye, AG; Balcha, TE; Woldeyohannes, AM, 2022) |
| "As sarcoidosis is a systemic disease that can affect any organ in the body, multimodality imaging is important in the diagnosis of sarcoidosis." | ( Aboye, AG; Balcha, TE; Woldeyohannes, AM, 2022) |
| "Sarcoidosis is a heterogeneous multisystem disease characterized by noncaseating granulomas." | ( Lan, X; Shao, F; Song, X, 2022) |
| "As sarcoidosis is a mimicking disease, a good differential diagnosis should be made to avoid misdiagnosis and in order not to be late in diagnosis and treatment." | ( Duruöz, MT; Esen, İ; Gezer, HH; Karabulut, Y; Öz, N, 2022) |
| "Sarcoidosis is a systemic granulomatous disorder affecting multiple organs including the lungs, skin, kidneys, and eyes." | ( Abe, S; Hayashi, I; Ichihara, K; Keino, H; Kohno, H; Miyoshi, S; Nakayama, M; Okada, AA; Okamoto, S; Saito, S; Takasaki, I; Tsuboshita, Y, 2022) |
| "Sarcoidosis is a systemic granulomatous disease of unknown etiology with significant heterogeneity in organ manifestations and clinical course." | ( Elahi, M; Koth, LL; Samavati, L; Steinbauer, B; Talreja, J, 2022) |
| "Sarcoidosis is a granulomatous disease of unknown etiology but is theorized to result from immune overactivity in the setting of an environmental or genetic trigger." | ( Evenson, CJ; Rosenbach, M; Shields, BE, 2023) |
| "Sarcoidosis is a granulomatous disease of unknown etiology but is theorized to result from immune overactivity in the setting of an environmental or genetic trigger." | ( Evenson, CJ; Rosenbach, M; Shields, BE, 2023) |
| "Cardiac sarcoidosis is associated with a high mortality rate." | ( Al-Hakim, T; An, A; Buchanan, M; Heise, R; Martinez, J; Nicholson, S; Osborne, JR; Singh, P; Subramanian, K; Van Parys, J; Youn, T, 2023) |
| "Cardiac sarcoidosis is associated with a high mortality rate." | ( Al-Hakim, T; An, A; Buchanan, M; Heise, R; Martinez, J; Nicholson, S; Osborne, JR; Singh, P; Subramanian, K; Van Parys, J; Youn, T, 2023) |
| "Sarcoidosis is a complex multisystem inflammatory disorder, with approximately 5% of patients having overt cardiac involvement." | ( Ahmad, M; Bray, JJH; Hylton, K; Ionescu, A; Khalid, AA; Kirresh, A; Ng, A; Providencia, R; Sharma, A; Siddiqui, A; Stevenson, A; Tregidgo, L, 2023) |
| "When neurosarcoidosis is suspected, other systemic manifestations are investigated to confirm the diagnosis." | ( Androdias, G; Fournier, N; Gerfaud-Valentin, M; Jamilloux, Y; Marignier, R; Sève, P; Streichenberger, N; Vukusic, S, 2023) |
| "Sarcoidosis is a multisystemic granulomatous disease of unknown etiology." | ( Benali, K; Régis, C; Rouzet, F, 2023) |
| "Sarcoidosis is primarily a disease of the lungs, and extrapulmonary manifestations are rare." | ( Cowman, BE; Pietila, M, 2022) |
| "Sarcoidosis is an idiopathic multisystem inflammatory disease that can affect virtually any part of the body." | ( Hosler, GA; Khalid, I; Ogwumike, E; Sode, T, 2023) |
| "Sarcoidosis is a systemic granulomatous disease with predominant pulmonary involvement and vast heterogeneity of clinical manifestations and disease outcomes." | ( Dawkins, BA; Iannuzzi, MC; Levin, AM; Li, C; Montgomery, CG; Pezant, N; Rasmussen, A; Rybicki, BA, 2023) |
| "Sarcoidosis is an inflammatory disorder in which patients frequently develop ocular manifestations that precede systemic involvement, sometimes it even presents as an ocular isolated form of the disease." | ( Concha-Del-Rio, LE; Hubbe-Tena, C; Salazar-Rodríguez, JA; Sarmiento-Forero, D, 2023) |
| "Sarcoidosis is a rare, underdiagnosed condition in Mexico and ocular involvement can be an early manifestation of the disease." | ( Concha-Del-Rio, LE; Hubbe-Tena, C; Salazar-Rodríguez, JA; Sarmiento-Forero, D, 2023) |
| "Tattoo-associated sarcoidosis is characterized by granulomas in tattoos with or without the involvement of other organ systems such as the lungs and eyes." | ( Brinth, LS; Danebod, K; Dreyer, M; Klarskov, CK, 2023) |
| "Background Sarcoidosis is an inflammatory, granulomatous disease of unknown cause affecting multiple organs, including the heart." | ( Asimaki, A; Behr, E; Bueno-Beti, C; Hamza, O; Hengstschläger, M; Kiss, A; Lim, CX; Mazic, M; Podesser, BK; Protonotarios, A; Sheppard, MN; Szabo, PL; Weichhart, T; Westaby, J, 2023) |
| "Sarcoidosis is a Th1-mediated chronic inflammatory disease characterized by non-caseating granulomas." | ( Akyildiz, M; Atabay, T; Gokduman, A; Kobak, S; Semiz, H; Vural, H, 2023) |
| "Sarcoidosis is a systemic inflammatory disease histologically defined by the non-caseation granulomas formation in different organs, most commonly lungs, liver, skin, gastrointestinal system, eyes, neurologic and cardiac system CASE PRESENTATION: We report the case of a 42-year-old Gilaks woman who presented with myelopathy with characteristic MRI finding called trident sign." | ( Azimi, AR; Doosti, R; Dousti, S; Heidari, H; Kohandel, K; Rabiei, P; Shahmohammdi, A; Shahmohammdi, S; Shajari, Z, 2023) |